Human medicines European public assessment report (EPAR): Erelzi, etanercept, Arthritis, Psoriatic,Psoriasis,Arthritis, Juvenile Rheumatoid,Arthritis, Rheumatoid,Spondylitis, Ankylosing, Date of authorisation: 23/06/2017, Revision: 4, Status: Authorised

Case Medical Research ◽

10.31525/cmr-208eb0e ◽

2019 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Juvenile Rheumatoid Arthritis ◽

Assessment Report ◽

Psoriasis Arthritis ◽

European Public ◽

European Public Assessment Report ◽

Spondylitis Ankylosing ◽

Arthritis Rheumatoid

Human medicines European public assessment report (EPAR): Enbrel, etanercept, Spondylitis, Ankylosing,Arthritis, Juvenile Rheumatoid,Arthritis, Psoriatic,Psoriasis,Arthritis, Rheumatoid, Date of authorisation: 02/02/2000, Revision: 59, Status: Authorised

Case Medical Research ◽

10.31525/cmr-59961a ◽

2019 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Juvenile Rheumatoid Arthritis ◽

Assessment Report ◽

Psoriasis Arthritis ◽

European Public ◽

European Public Assessment Report ◽

Spondylitis Ankylosing ◽

Arthritis Rheumatoid

Human medicines European public assessment report (EPAR): Enbrel, etanercept, Spondylitis, Ankylosing,Arthritis, Juvenile Rheumatoid,Arthritis, Psoriatic,Psoriasis,Arthritis, Rheumatoid, Date of authorisation: 02/02/2000, Revision: 58, Status: Authorised

Case Medical Research ◽

10.31525/cmr-5970b9 ◽

2019 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Juvenile Rheumatoid Arthritis ◽

Assessment Report ◽

Psoriasis Arthritis ◽

European Public ◽

European Public Assessment Report ◽

Spondylitis Ankylosing ◽

Arthritis Rheumatoid

Human medicines European public assessment report (EPAR): Idacio, adalimumab, Arthritis, Rheumatoid,Arthritis, Juvenile Rheumatoid,Psoriasis,Arthritis, Psoriatic,Spondylitis, Ankylosing,Uveitis,Hidradenitis Suppurativa,Colitis, Ulcerative,Crohn Disease, Date of authorisation: 02/04/2019, Status: Authorised

Case Medical Research ◽

10.31525/cmr-105efa3 ◽

2019 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Crohn Disease ◽

Hidradenitis Suppurativa ◽

Assessment Report ◽

Psoriasis Arthritis ◽

European Public ◽

European Public Assessment Report ◽

Colitis Ulcerative ◽

Spondylitis Ankylosing ◽

Arthritis Rheumatoid

Human medicines European public assessment report (EPAR): Nordimet, methotrexate, Arthritis, Psoriatic,Psoriasis,Arthritis, Juvenile Rheumatoid,Arthritis, Rheumatoid, Date of authorisation: 18/08/2016, Revision: 8, Status: Authorised

Case Medical Research ◽

10.31525/cmr-d7cc27 ◽

2019 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Juvenile Rheumatoid Arthritis ◽

Assessment Report ◽

Psoriasis Arthritis ◽

European Public ◽

European Public Assessment Report ◽

Arthritis Rheumatoid

Human medicines European public assessment report (EPAR): Nordimet, methotrexate, Arthritis, Psoriatic,Psoriasis,Arthritis, Juvenile Rheumatoid,Arthritis, Rheumatoid, Date of authorisation: 18/08/2016, Revision: 6, Status: Authorised

Case Medical Research ◽

10.31525/cmr-d8201f ◽

2019 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Juvenile Rheumatoid Arthritis ◽

Assessment Report ◽

Psoriasis Arthritis ◽

European Public ◽

European Public Assessment Report ◽

Arthritis Rheumatoid

Human medicines European public assessment report (EPAR): Kromeya, adalimumab, Arthritis, Rheumatoid,Arthritis, Juvenile Rheumatoid,Psoriasis,Arthritis, Psoriatic,Spondylitis, Ankylosing,Uveitis,Colitis, Ulcerative,Crohn Disease, Date of authorisation: 02/04/2019, Revision: 2, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1122302 ◽

2019 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Crohn Disease ◽

Assessment Report ◽

Psoriasis Arthritis ◽

European Public ◽

European Public Assessment Report ◽

Colitis Ulcerative ◽

Spondylitis Ankylosing ◽

Arthritis Rheumatoid

Human medicines European public assessment report (EPAR): Idacio, adalimumab, Arthritis, Rheumatoid,Arthritis, Juvenile Rheumatoid,Psoriasis,Arthritis, Psoriatic,Spondylitis, Ankylosing,Uveitis,Hidradenitis Suppurativa,Colitis, Ulcerative,Crohn Disease, Date of authorisation: 02/04/2019, Revision: 1, Status: Authorised

Case Medical Research ◽

10.31525/cmr-106e821 ◽

2019 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Crohn Disease ◽

Hidradenitis Suppurativa ◽

Assessment Report ◽

Psoriasis Arthritis ◽

European Public ◽

European Public Assessment Report ◽

Colitis Ulcerative ◽

Spondylitis Ankylosing ◽

Arthritis Rheumatoid

Human medicines European public assessment report (EPAR): Kromeya, adalimumab, Arthritis, Rheumatoid,Arthritis, Juvenile Rheumatoid,Psoriasis,Arthritis, Psoriatic,Spondylitis, Ankylosing,Uveitis,Colitis, Ulcerative,Crohn Disease, Date of authorisation: 02/04/2019, Status: Authorised

Case Medical Research ◽

10.31525/cmr-112db4f ◽

2019 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Crohn Disease ◽

Assessment Report ◽

Psoriasis Arthritis ◽

European Public ◽

European Public Assessment Report ◽

Colitis Ulcerative ◽

Spondylitis Ankylosing ◽

Arthritis Rheumatoid

Human medicines European public assessment report (EPAR): Amsparity, adalimumab, Arthritis, Rheumatoid,Arthritis, Juvenile Rheumatoid,Psoriasis,Arthritis, Psoriatic,Spondylitis, Ankylosing,Uveitis,Colitis, Ulcerative,Crohn Disease,Hidradenitis Suppurativa, Date of authorisation: 13/02/2020, Status: Authorised

Case Medical Research ◽

10.31525/cmr-29603ff ◽

2020 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Crohn Disease ◽

Hidradenitis Suppurativa ◽

Assessment Report ◽

Psoriasis Arthritis ◽

European Public ◽

European Public Assessment Report ◽

Colitis Ulcerative ◽

Spondylitis Ankylosing ◽

Arthritis Rheumatoid